{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Mutant ataxin-3 abnormally interacted with CCT5, a subunit of the CCT chaperonin complex, as shown by co-immunoprecipitation.",
  "functions": [
    {
      "function": "Chaperonin-Mediated Protein Folding (Pathological)",
      "arrow": "inhibits",
      "cellular_process": "Mutant, polyQ-expanded ataxin-3 pathologically interacts with CCT5, a subunit of the essential cytosolic chaperonin complex CCT/TRiC. This complex is vital for the proper folding of a significant portion of newly synthesized proteins, including crucial cytoskeletal components like actin and tubulin.",
      "effect_description": "The abnormal binding and sequestration of CCT5 and other CCT/TRiC components into aggregates with mutant ATXN3 impairs the overall cellular protein folding capacity. This disruption of proteostasis is believed to contribute significantly to the accumulation of misfolded proteins and the formation of toxic aggregates characteristic of Spinocerebellar Ataxia Type 3 (SCA3).",
      "biological_consequence": [
        "Mutant ATXN3 (polyQ-expanded) binds to CCT5 → Sequestration and functional impairment of the CCT/TRiC chaperonin complex → Disruption of folding for nascent polypeptides (e.g., actin, tubulin) → Increased burden of misfolded proteins and aggregate formation → Cellular proteotoxicity and neurodegeneration in SCA3"
      ],
      "specific_effects": [
        "The pathological interaction was identified via co-immunoprecipitation and proteomics in a SCA3 knock-in mouse model (Ki150) expressing ATXN3 with a long polyglutamine tract.",
        "This interaction represents a toxic gain-of-function for mutant ATXN3, leading to the impairment of a critical cellular quality control pathway."
      ],
      "evidence": [
        {
          "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
          "journal": "Scientific Reports",
          "year": 2023,
          "relevant_quote": "We fractionated ataxin-3-positive large complexes and independently we pulled-down ataxin-3 from brain lysates, and both were followed by proteomics. Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b.",
          "pmid": "37033372"
        }
      ],
      "pathway": {
        "name": "Protein Folding",
        "canonical_name": "Protein Folding",
        "ontology_id": "GO:0006457",
        "ontology_source": "GO",
        "confidence": 0.8
      },
      "pmids": [
        "37033372"
      ],
      "interaction_effect": "inhibition",
      "interaction_direction": "main_to_primary",
      "function_effect": "inhibition"
    }
  ],
  "arrow": "inhibits",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "Mutant, polyQ-expanded ataxin-3 pathologically interacts with CCT5, a subunit of the essential cytosolic chaperonin complex CCT/TRiC. This complex is vital for the proper folding of a significant portion of newly synthesized proteins, including crucial cytoskeletal components like actin and tubulin.",
  "effect": "The abnormal binding and sequestration of CCT5 and other CCT/TRiC components into aggregates with mutant ATXN3 impairs the overall cellular protein folding capacity. This disruption of proteostasis is believed to contribute significantly to the accumulation of misfolded proteins and the formation of toxic aggregates characteristic of Spinocerebellar Ataxia Type 3 (SCA3).",
  "summary": "ATXN3 inhibits CCT5 to modulate chaperonin-mediated protein folding (pathological), ultimately affecting cellular proteotoxicity and neurodegeneration in sca3.",
  "evidence": [
    {
      "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
      "journal": "Scientific Reports",
      "year": 2023,
      "relevant_quote": "We fractionated ataxin-3-positive large complexes and independently we pulled-down ataxin-3 from brain lysates, and both were followed by proteomics. Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b."
    }
  ],
  "pathways": [
    {
      "name": "Protein Folding",
      "canonical_name": "Protein Folding",
      "ontology_id": "GO:0006457",
      "ontology_source": "GO",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --inhibits--> CCT5:",
  "protein_a": "CCT5",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-07T22:39:21.517507Z",
  "last_updated": "2025-12-07T22:39:21.517507Z"
}